← Open Payments lookup

JAIME ACKERMAN: Open Payments

NPI 1013992544 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$44,326 in 201 payments from 19 companies in 2025. Trend: 2023 $3,732 · 2024 $26,490 · 2025 $44,326

Speaker / faculty: $30,059Travel & lodging: $8,288Food & beverage: $3,869Consulting: $2,100Education: $10
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC60$20,121
Phathom Pharmaceuticals, Inc.36$13,530
Ardelyx, Inc.19$8,924
ABBVIE INC.33$592
Lilly USA, LLC12$198
Janssen Biotech, Inc.10$195
QOL Medical, LLC5$172
Takeda Pharmaceuticals U.S.A., Inc.8$146
GENZYME CORPORATION4$101
Madrigal Pharmaceuticals3$85

Products named: VOQUEZNA, IBSRELA, XIFAXAN, RELISTOR, TRULANCE, OMVOH, TREMFYA, RINVOQ.

Industry payments across GA — which companies pay providers there.